Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2003 Oct 30;349(18):1722-9.
doi: 10.1056/NEJMoa031237.

Somatic and germ-line mutations of the HRPT2 gene in sporadic parathyroid carcinoma

Trisha M Shattuck  1 , Stiina Välimäki, Takao Obara, Randall D Gaz, Orlo H Clark, Dolores Shoback, Margaret E Wierman, Katsuyoshi Tojo, Christiane M Robbins, John D Carpten, Lars-Ove Farnebo, Catharina Larsson, Andrew Arnold
Affiliations
Free article

Somatic and germ-line mutations of the HRPT2 gene in sporadic parathyroid carcinoma

Trisha M Shattuck et al. N Engl J Med. .
Free article

Abstract

Background: We looked for mutations of the HRPT2 gene, which encodes the parafibromin protein, in sporadic parathyroid carcinoma because germ-line inactivating HRPT2 mutations have been found in a type of familial hyperparathyroidism--hyperparathyroidism-jaw tumor (HPT-JT) syndrome--that carries an increased risk of parathyroid cancer.

Methods: We directly sequenced the full coding and flanking splice-junctional regions of the HRPT2 gene in 21 parathyroid carcinomas from 15 patients who had no known family history of primary hyperparathyroidism or the HPT-JT syndrome at presentation. We also sought to confirm the somatic nature of the identified mutations and tested the carcinomas for tumor-specific loss of heterozygosity at HRPT2.

Results: Parathyroid carcinomas from 10 of the 15 patients had HRPT2 mutations, all of which were predicted to inactivate the encoded parafibromin protein. Two distinct HRPT2 mutations were found in tumors from five patients, and biallelic inactivation as a result of a mutation and loss of heterozygosity was found in one tumor. At least one HRPT2 mutation was demonstrably somatic in carcinomas from six patients. Unexpectedly, HRPT2 mutations in the parathyroid carcinomas of three patients were identified as germ-line mutations.

Conclusions: Sporadic parathyroid carcinomas frequently have HRPT2 mutations that are likely to be of pathogenetic importance. Certain patients with apparently sporadic parathyroid carcinoma carry germ-line mutations in HRPT2 and may have the HPT-JT syndrome or a phenotypic variant.

PubMed Disclaimer

Comment in

  • HRPT2, a marker of parathyroid cancer.
    Weinstein LS, Simonds WF. Weinstein LS, et al. N Engl J Med. 2003 Oct 30;349(18):1691-2. doi: 10.1056/NEJMp038159. N Engl J Med. 2003. PMID: 14585935 No abstract available.

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

Publication types

LinkOut - more resources